All Articles

Sunrun reports a major financial turnaround, pivoting to a storage-first strategy that turns home batteries into a powerful virtual power plant.

The safety solutions leader adds a top CFO and CEO to its board, a strategic move to bolster financial oversight and drive growth amid record performance.

After a strategic pivot to focus purely on cell and gene therapy, BioLife reports strong revenue growth and a profitable quarter, eyeing further gains in 2026.

Neurizon Therapeutics has started dosing its promising ALS drug, NUZ-001, in the groundbreaking HEALEY Platform Trial, a pivotal step for patients.

Facing user burnout and fierce rivals, Tinder's first-ever product event aims to reignite the flame. Can new tech and a new vision save the dating giant?

The AI semiconductor firm posts 37% annual revenue growth and a return to non-GAAP profit, proving its strategic pivot to intelligent edge devices is a success.

Structure Therapeutics reports strong Phase 2 data for its oral obesity pill, aleniglipron, positioning it as a key contender in the race for pill-based GLP-1s.

The 3M spin-off navigates a transformative year, posting strong organic growth driven by MedSurg and Dental, despite a reported sales dip from divestitures.

FTAI Infrastructure's aggressive acquisitions drove an 82% jump in adjusted earnings, but hefty debt and transaction costs led to a significant net loss.

With a new $15M share repurchase program, Epsilon Energy shows strong belief in its undervalued stock, leveraging a debt-free balance sheet to boost value.

Skydio's autonomous drones have answered 10 million calls, powered by deep integration that gets eyes on scene in under 60 seconds. But what does this mean?

A new study shows alternating magnetic fields can destroy antibiotic-resistant biofilms on medical implants, offering hope for a non-surgical treatment.

NuScale Power touts a 'breakthrough year' with landmark deals, but staggering financial losses and partner scrutiny test its path to commercialization.

The ad tech firm's stock surged on a strong Q4, but a full-year loss highlights its high-stakes pivot to AI and CTV to fuel future growth.

Clipper Realty's Q4 results show a stark divide in NYC real estate, as soaring apartment rents struggle to offset deep losses from its troubled office portfolio.

With TGA approval, Optellum's AI platform arrives to help tackle Australia's low lung cancer survival rates by enabling earlier, more accurate detection.

With Phase 3 epilepsy results for its lead drug azetukalner due in March, Xenon reveals a major R&D spend and a cash runway to fuel its broad pipeline.

Nearing 400 shops, the superfruit bowl brand's rapid growth is fueled by savvy franchisees, private equity backing, and a major push into global markets.

Facing a surge in malvertising and fraud, giants like Amazon and Microsoft join The Media Trust's new council to build a collective industry defense.

The 157-year-old institution launches a modern suite of accounts, blending digital tools with tailored options to compete in Western Massachusetts.